How Concomitant Medications Affect Cancer Immunotherapy Outcomes
The ever-evolving landscape of cancer treatment is witnessing remarkable strides, particularly with the advent of immune checkpoint inhibitors (ICIs). These ...
Tag: immune-related adverse events
Adverse Effects of PD-1/PD-L1 Therapy in Merkel Cell Carcinoma
In recent years, the treatment landscape for Merkel cell carcinoma (MCC), a rare yet aggressive form of skin cancer, has ...
Navigating Melanoma Immunotherapy in Compromised Immune Systems
Immunotherapy has revolutionized the treatment landscape for melanoma, particularly in the last decade. However, as the potential for these innovative ...
PD-1/PD-L1 Inhibitors Boost Nasopharyngeal Cancer Outcomes
In the ever-evolving battle against cancer, nasopharyngeal carcinoma (NPC) stands out due to its unique challenges in treatment and management. ...
Immune Checkpoint Inhibitors Linked to Elevated Myocarditis Risk in NSCLC Patients
A groundbreaking editorial recently published in the latest volume of Oncoscience sheds new light on the complex relationship between immune ...
